NLRP3 and breast cancer: In addition, NLRP3 inhibition proved to be protective against IL-1β upregulation in peritumoral astrocytes in the mouse breast cancer brain metastasis model, resulting in an approximately 75% decrease in the percentage of IL-1β- and GFAP-double-positive pixels (Fig. 6a, b).